BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24504124)

  • 1. The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).
    Bogaerts E; Heindryckx F; Vandewynckel YP; Van Grunsven LA; Van Vlierberghe H
    Int J Oncol; 2014 Apr; 44(4):1015-22. PubMed ID: 24504124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.
    Guest RV; Boulter L; Kendall TJ; Minnis-Lyons SE; Walker R; Wigmore SJ; Sansom OJ; Forbes SJ
    Cancer Res; 2014 Feb; 74(4):1005-10. PubMed ID: 24310400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials.
    Lee SH; Jeong YS; Lee S; Sohn BH; Hwang HK; Choi GH; Kang CM; Choi JS; Lee WJ; Cheong JH; Jang HJ; Kaseb A; Roberts L; Yim SY; Chun YS; Lee JS
    Cancer Commun (Lond); 2022 Feb; 42(2):179-183. PubMed ID: 35032367
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease.
    Michalopoulos GK; Khan Z
    Gastroenterology; 2015 Oct; 149(4):876-882. PubMed ID: 26278502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal multicellularity and polarity without Wnt signaling.
    Schenkelaars Q; Pratlong M; Kodjabachian L; Fierro-Constain L; Vacelet J; Le Bivic A; Renard E; Borchiellini C
    Sci Rep; 2017 Nov; 7(1):15383. PubMed ID: 29133828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transcriptomic Signature of Mouse Liver Progenitor Cells.
    Passman AM; Low J; London R; Tirnitz-Parker JE; Miyajima A; Tanaka M; Strick-Marchand H; Darlington GJ; Finch-Edmondson M; Ochsner S; Zhu C; Whelan J; Callus BA; Yeoh GC
    Stem Cells Int; 2016; 2016():5702873. PubMed ID: 27777588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.
    Guest RV; Boulter L; Dwyer BJ; Forbes SJ
    NPJ Regen Med; 2017; 2():13. PubMed ID: 29302349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of liver cancer stem cells.
    Oishi N; Yamashita T; Kaneko S
    Liver Cancer; 2014 May; 3(2):71-84. PubMed ID: 24944998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
    Bogaerts E; Heindryckx F; Devisscher L; Paridaens A; Vandewynckel YP; Van den Bussche A; Verhelst X; Libbrecht L; van Grunsven LA; Geerts A; Van Vlierberghe H
    PLoS One; 2015; 10(3):e0119555. PubMed ID: 25793288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition.
    Derynck R; Muthusamy BP; Saeteurn KY
    Curr Opin Cell Biol; 2014 Dec; 31():56-66. PubMed ID: 25240174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of Notch signaling in liver disease.
    Geisler F; Strazzabosco M
    Hepatology; 2015 Jan; 61(1):382-92. PubMed ID: 24930574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury.
    Tarlow BD; Finegold MJ; Grompe M
    Hepatology; 2014 Jul; 60(1):278-89. PubMed ID: 24700457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.
    Giannelli G; Villa E; Lahn M
    Cancer Res; 2014 Apr; 74(7):1890-4. PubMed ID: 24638984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
    Sartorius K; Antwi SO; Chuturgoon A; Roberts LR; Kramvis A
    Front Oncol; 2022; 12():891812. PubMed ID: 35600358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities.
    Garmpis N; Damaskos C; Garmpi A; Georgakopoulou VE; Sarantis P; Antoniou EA; Karamouzis MV; Nonni A; Schizas D; Diamantis E; Koustas E; Farmaki P; Syllaios A; Patsouras A; Kontzoglou K; Trakas N; Dimitroulis D
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33809844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SVF-derived extracellular vesicles carry characteristic miRNAs in lipedema.
    Priglinger E; Strohmeier K; Weigl M; Lindner C; Auer D; Gimona M; Barsch M; Jacak J; Redl H; Grillari J; Sandhofer M; Hackl M; Wolbank S
    Sci Rep; 2020 Apr; 10(1):7211. PubMed ID: 32350368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt Signaling: Paths for Cancer Progression.
    Carreira-Barbosa F; Nunes SC
    Adv Exp Med Biol; 2020; 1219():189-202. PubMed ID: 32130700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma in a Patient with Hereditary Hemorrhagic Telangiectasia.
    Morii K; Uematsu R; Yamamoto T; Nakamura S; Okushin H; Nishiwaki N; Watanabe T; Kai K; Sato S
    Intern Med; 2018 Dec; 57(24):3545-3549. PubMed ID: 30146556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Garlic-derived compound
    Xiao J; Xing F; Liu Y; Lv Y; Wang X; Ling MT; Gao H; Ouyang S; Yang M; Zhu J; Xia Y; So KF; Tipoe GL
    Acta Pharm Sin B; 2018 Jul; 8(4):575-586. PubMed ID: 30109182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance.
    Khalaf AM; Fuentes D; Morshid AI; Burke MR; Kaseb AO; Hassan M; Hazle JD; Elsayes KM
    J Hepatocell Carcinoma; 2018; 5():61-73. PubMed ID: 29984212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.